Patient perspectives on fluticasone–vilanterol versus other corticosteroid combination products for the treatment of asthma

References

• Global Strategy for Asthma Management and PreventionGlobal Iniative for Asthma (GINA)2016 Available from: http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/Accessed April 25, 2016
   Google Scholar
• Centers for Disease Control and PreventionSurvey reveals growing national impact of asthma Available from: http://www.cdc.gov/media/releases/2012/p0515_asthma_impact.htmlAccessed April 25, 2016
   Google Scholar
• O’HallarenMTSudden death from asthma: is your patient at risk? Available from: http://www.medscape.org/viewarticle/512066_2Accessed April 25, 2016
   Google Scholar
• Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdfAccessed January 28, 2016
   Google Scholar
• BatemanEDBousheHABousquetJCan guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control StudyAm J Respir Crit Care Med200417083684415256389
   PubMed Web of Science ®Google Scholar
• MoonieSStrunkRCCrockerSCurtisVSchechtmanKCastroMCommunity asthma program improves appropriate prescribing in moderate to severe asthmaJ Asthma20054228128916032937
   PubMed Web of Science ®Google Scholar
• ScichiloneNContinoAFiglioliGBPaglinoGBelliaVPatient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment optionsPatient Prefer Adherence20104172320165595
   PubMed Web of Science ®Google Scholar
• SeidMOpipari-ArriganLGelhardLRVarniJWDriscollKBarriers to care questionnaire: reliability, validity, and responsiveness to change among parents of children with asthmaAcad Pediatr2009910611319329101
   PubMed Web of Science ®Google Scholar
• BroedersMSanchisJLevyMLCromptonGKDekhuijzenPNThe ADMIT series: issues in inhalation therapy. 2) Improving technique and clinical effectivenessPrim Care Respir J200918768219475324
   PubMedGoogle Scholar
• SleathBAyalaGXGilleteCProvider demonstration and assessment of child device technique during pediatric asthma visitsPediatrics2011127643648
   Web of Science ®Google Scholar
• DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: evidenced-based guidelinesChest200512733537115654001
   PubMed Web of Science ®Google Scholar
• LasterNHolseyCNShendellDGMcCartyFACelanoMBarriers to asthma management among urban families: caregiver and child perspectivesJ Asthma20094673173919728215
   PubMed Web of Science ®Google Scholar
• MansourMELanphearBPDeWittTGBarriers to asthma care in urban children: patient perspectivesPediatrics200010651251910969096
   PubMed Web of Science ®Google Scholar
• FischerMAChoudhryNKBrillGTrouble getting started; predictors of primary medication nonadherenceAm J Med20111241081.e91081.e2222017787
   PubMed Web of Science ®Google Scholar
• BouletLPVervloetDMagarYFosterJMAdherence: the goal to control asthmaClin Chest Med20123340541722929091
   PubMed Web of Science ®Google Scholar
• KlokTLubbersSKapteinAABrandPLEvery parent tells a store: why non-adherence may persist in children receiving guideline-based comprehensive asthma careJ Asthma20145110611224007568
   PubMed Web of Science ®Google Scholar
• BenderBGLongAParasuramanBTranZVFactors influencing patient decisions about the use of asthma controller medicationAnn Allergy Asthma Immunol20079832232817458427
   PubMed Web of Science ®Google Scholar
• GuptaGKAgrawalDKCpG oligodeoxynucleotides as TLR9 agonistsBiodrugs20102422523520623989
   PubMed Web of Science ®Google Scholar
• MengLHeXZhuWTLR3 and TLR7 modulate IgE production in antigen induced pulmonary inflammation via influencing IL-4 expression in immune organsPLoS One201162e1725221364926
   PubMed Web of Science ®Google Scholar
• StollMLSolomonDHBatraKLTNFα inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthmaJ Clin Rheumatol20091519820019455057
   PubMed Web of Science ®Google Scholar
• Breo [homepage on the Internet] Available from: http://www.mybreo.com/asthma.htmlAccessed January 28, 2016
   Google Scholar
• emc+Fostair NEXThaler product information Available from: http://www.medicines.org.uk/emc/medicine/29177Accessed January 21, 2016
   Google Scholar
• emc+Fostair inhalation solution product information Available from: http://www.medicines.org.uk/emc/medicine/21474Accessed January 21, 2016
   Google Scholar
• Facts and Comparisons eAnswers Available from: http://online.factsandcomparisons.com/MonoDisp.aspx?monoID=fandc-hcp12879&quick=650717%7c5&search=650717%7c5&isstemmed=True&NDCmapping=-1&fromTop=true#firstMatchAccessed January 28, 2016
   Google Scholar
• SalterMBiggadikeKMatthewsJLPharmacologic properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory diseaseAm J Physiol Lung Cell Mol Physiol2007293L660L66717575011
   PubMed Web of Science ®Google Scholar
• RossiosCToYToMLong acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cellsEur J Pharmacol201167024425121920359
   PubMed Web of Science ®Google Scholar
• AllenABareillePJRousellVMFluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionateClin Pharmacokinet201352374223184737
   PubMed Web of Science ®Google Scholar
• MalerbaMRadaeliAMorjarioaJBTherapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspectsDrug Discov Today20121749650422119310
   PubMed Web of Science ®Google Scholar
• BjergALundbackBLotvallJThe future of combining inhaled drugs for COPDCurr Opin Pharmacol20121225225522465638
   PubMed Web of Science ®Google Scholar
• CazzolaMPageCPCalzettaLMateraMGPharmacology and therapeutics of bronchodilatorsPharmacol Rev20126445050422611179
   PubMed Web of Science ®Google Scholar
• BatemanEDBleeckerERLotvallJDose effect of once-daily fluticasone furoate in persistent asthma: a randomized trialRespir Med201210664265022342538
   PubMed Web of Science ®Google Scholar
• BleeckerERBatemanEDBusseWWOnce-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroidsAnn Allergy Asthma Immunol201210935335823062392
   PubMed Web of Science ®Google Scholar
• BusseWBleeckerERBatemanEDFluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomized, placebo-controlled trialThorax201267354121828231
   PubMed Web of Science ®Google Scholar
• LotvallJBleeckerERBusseWWEfficacy and safety of fluticasone furoate 100mcg once-daily in patients with persistent asthma: a 24 week placebo and active-controlled randomized trialRespir Med2014108414924295556
   PubMed Web of Science ®Google Scholar
• OliverAQuinnDGoldfradCvan HeckeBAyerJBoyceMCombined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomized, controlled trialClin Transl Allergy20122112022738148
   PubMedGoogle Scholar
• OliverABjermerLQuinnDModulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combinationAllergy2013681136114223924233
   PubMed Web of Science ®Google Scholar
• O’ByrnePMBleeckerERBatemanEDOnce-daily fluticasone furoate alone or combined with vilanterol in persistent asthmaEur Respir J20144377378224136330
   PubMed Web of Science ®Google Scholar
• BatemanEDO’ByrnePMBusseWWOnce-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF aloneThorax20146931231924253831
   PubMed Web of Science ®Google Scholar
• WoodcockABleeckerERLotvallJEfficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthmaChest20131441222122923846316
   PubMed Web of Science ®Google Scholar
• BusseWWO’ByrnePMBleeckerERSafety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients $12 years old with asthma: a randomized trialThorax20136851352023440247
   PubMed Web of Science ®Google Scholar
• OliverAVanBurenSAllenATolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthmaClin Ther20143692893924793536
   PubMed Web of Science ®Google Scholar
• AllenASchenkenbergerITrivediRInhaled fluticasone furoate/vilanterol dose not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomized, double-blind, placebo-controlled studyClin Respir J2013739740623578031
   PubMed Web of Science ®Google Scholar
• KempsfordRDOliverABalJTombsLQuinnDThe efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening doseRespir Med20131071873188024200619
   PubMed Web of Science ®Google Scholar
• RolandNJBhallaRKEarisJThe local side effects of inhaled corticosteroids. Current understanding and review of the literatureChest200412621321915249465
   PubMed Web of Science ®Google Scholar
• LipworthBJSystemic adverse effects of inhaled corticosteroidsArch Intern Med199915994195510326936
   PubMed Web of Science ®Google Scholar
• NelsonHSWeissSTBleeckerERYanceySWDorinskyPMThe Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterolChest2006129152616424409
   PubMed Web of Science ®Google Scholar
• MarceauCLemiereCBerbicheDPerreaultSBlaisLPersistence, adherence, and effectiveness of combination therapy among adult patients with asthmaJ Allergy Clin Immunol200618857458116950273
   PubMed Web of Science ®Google Scholar
• StoloffSWStempelDAMeyerJStanfordRHRosenzweigRJCImproved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapiesJ Allergy Clin Immunol200411324525114767437
   PubMed Web of Science ®Google Scholar
• StempelDAStoloffSWRosenzweigJRCStanfordRHRyskinaKLLegorretaAPAdherence to asthma controller medication regimensRespir Med2005991263126716140227
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE)Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over2008 Available from: guidance.nice.org/uk/ta138Accessed September 11, 2015
   Google Scholar
• FDA.gov [homepage on the Internet] http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htmlAccessed January 28, 2016
   Google Scholar
• NicoliniGScichilonNBizziAPapiAFabbriLMBeclomethasone/formoterol fixed combination for the management of asthma: patient considerationsTher Clin Risk Manag2008485586419209268
   PubMedGoogle Scholar
• InCheck Dial [homepage on the Internet] Available from: http://www.clement-clarke.com/ProductInfo/InhalerTechniqueTraining/InCheckDIAL.aspxAccessed January 28, 2016
   Google Scholar
• 2Tone Trainer product information Available from: http://2tonetrainer.net/Accessed January 28, 2016
   Google Scholar
• SvedsaterHJacquesLGoldfradCEase of use of ELLIPTA dry powder inhaler: data from three randomized controlled trials in patients with asthmaPrimary Care Respir Med20142414019
   PubMed Web of Science ®Google Scholar
• SvedsaterHDalePGarrillKWalkerRWoepseMWQualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPDBMC Pulm Med2013137224314123
   PubMed Web of Science ®Google Scholar
• PapiAHaughneyJVirchowJCRocheNPalkonenSPriceDInhaler devices for asthma: a call for action in a neglected fieldEur Respir J20113798298521532013
   PubMed Web of Science ®Google Scholar
• WilsonSRStrubPBuistASShared treatment decision making improves adherence and outcomes in poorly controlled asthmaAm J Respir Crit Care Med201018156657720019345
   PubMed Web of Science ®Google Scholar
• PRNewswireMylan confirms FDA submission of ANDA for Generic Advair Diskus Available from: http://www.prnewswire.com/news-releases/mylan-confirms-fda-submission-of-anda-for-generic-advair-diskus-300202571.htmlAccessed January 28, 2016
   Google Scholar